195 related articles for article (PubMed ID: 24895996)
1. miR-148a- and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activity.
Bofill-De Ros X; Gironella M; Fillat C
Mol Ther; 2014 Sep; 22(9):1665-77. PubMed ID: 24895996
[TBL] [Abstract][Full Text] [Related]
2. Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cells.
Bofill-De Ros X; Villanueva E; Fillat C
Oncotarget; 2015 Mar; 6(8):6179-90. PubMed ID: 25714032
[TBL] [Abstract][Full Text] [Related]
3. Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer.
Rovira-Rigau M; Raimondi G; Marín MÁ; Gironella M; Alemany R; Fillat C
Mol Ther; 2019 Jan; 27(1):230-243. PubMed ID: 30341009
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models.
Huch M; Gros A; José A; González JR; Alemany R; Fillat C
Neoplasia; 2009 Jun; 11(6):518-28, 4 p following 528. PubMed ID: 19484141
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses.
Raimondi G; Mato-Berciano A; Pascual-Sabater S; Rovira-Rigau M; Cuatrecasas M; Fondevila C; Sánchez-Cabús S; Begthel H; Boj SF; Clevers H; Fillat C
EBioMedicine; 2020 Jun; 56():102786. PubMed ID: 32460166
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.
Liffers ST; Munding JB; Vogt M; Kuhlmann JD; Verdoodt B; Nambiar S; Maghnouj A; Mirmohammadsadegh A; Hahn SA; Tannapfel A
Lab Invest; 2011 Oct; 91(10):1472-9. PubMed ID: 21709669
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic Adenovirus Expressing ST13 Increases Antitumor Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Against Pancreatic Ductal Adenocarcinoma.
Zhang Y; Ye M; Huang F; Wang S; Wang H; Mou X; Wang Y
Hum Gene Ther; 2020 Aug; 31(15-16):891-903. PubMed ID: 32475172
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor activity of a miR-199-dependent oncolytic adenovirus.
Callegari E; Elamin BK; D'Abundo L; Falzoni S; Donvito G; Moshiri F; Milazzo M; Altavilla G; Giacomelli L; Fornari F; Hemminki A; Di Virgilio F; Gramantieri L; Negrini M; Sabbioni S
PLoS One; 2013; 8(9):e73964. PubMed ID: 24069256
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation.
Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Okato A; Arai T; Kita Y; Mataki Y; Kijima Y; Maemura K; Natsugoe S
Cancer Sci; 2018 Jun; 109(6):2013-2026. PubMed ID: 29660218
[TBL] [Abstract][Full Text] [Related]
10. MiR-216a decreases MALAT1 expression, induces G2/M arrest and apoptosis in pancreatic cancer cells.
Zhang Y; Tang X; Shi M; Wen C; Shen B
Biochem Biophys Res Commun; 2017 Feb; 483(2):816-822. PubMed ID: 28034748
[TBL] [Abstract][Full Text] [Related]
11. Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors.
Gayral M; Lulka H; Hanoun N; Biollay C; Sèlves J; Vignolle-Vidoni A; Berthommé H; Trempat P; Epstein AL; Buscail L; Béjot JL; Cordelier P
Hum Gene Ther; 2015 Feb; 26(2):104-13. PubMed ID: 25423447
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-mediated suppression of oncolytic adenovirus replication in human liver.
Ylösmäki E; Lavilla-Alonso S; Jäämaa S; Vähä-Koskela M; af Hällström T; Hemminki A; Arola J; Mäkisalo H; Saksela K
PLoS One; 2013; 8(1):e54506. PubMed ID: 23349911
[TBL] [Abstract][Full Text] [Related]
13. HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.
Xu HN; Huang WD; Cai Y; Ding M; Gu JF; Wei N; Sun LY; Cao X; Li HG; Zhang KJ; Liu XR; Liu XY
Mol Cancer; 2011 Nov; 10():133. PubMed ID: 22040050
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
[TBL] [Abstract][Full Text] [Related]
15. Strong antitumor efficacy of a pancreatic tumor-targeting oncolytic adenovirus for neuroendocrine tumors.
Yamamoto Y; Nagasato M; Rin Y; Henmi M; Ino Y; Yachida S; Ohki R; Hiraoka N; Tagawa M; Aoki K
Cancer Med; 2017 Oct; 6(10):2385-2397. PubMed ID: 28941156
[TBL] [Abstract][Full Text] [Related]
16. The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells.
Man YKS; Davies JA; Coughlan L; Pantelidou C; Blázquez-Moreno A; Marshall JF; Parker AL; Halldén G
Mol Cancer Ther; 2018 Feb; 17(2):575-587. PubMed ID: 29367266
[TBL] [Abstract][Full Text] [Related]
17. Advances in oncolytic adenovirus therapy for pancreatic cancer.
Nattress CB; Halldén G
Cancer Lett; 2018 Oct; 434():56-69. PubMed ID: 29981812
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models.
Miao T; Symonds A; Hickman OJ; Wu D; Wang P; Lemoine N; Wang Y; Linardopoulos S; Halldén G
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279262
[TBL] [Abstract][Full Text] [Related]
19. Deletion of pancreas-specific miR-216a reduces beta-cell mass and inhibits pancreatic cancer progression in mice.
Erener S; Ellis CE; Ramzy A; Glavas MM; O'Dwyer S; Pereira S; Wang T; Pang J; Bruin JE; Riedel MJ; Baker RK; Webber TD; Lesina M; Blüher M; Algül H; Kopp JL; Herzig S; Kieffer TJ
Cell Rep Med; 2021 Nov; 2(11):100434. PubMed ID: 34841287
[TBL] [Abstract][Full Text] [Related]
20. A genetic fiber modification to achieve matrix-metalloprotease-activated infectivity of oncolytic adenovirus.
José A; Rovira-Rigau M; Luna J; Giménez-Alejandre M; Vaquero E; García de la Torre B; Andreu D; Alemany R; Fillat C
J Control Release; 2014 Oct; 192():148-56. PubMed ID: 25037019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
